The stock price of Nutrien Ltd (NYSE: NTR) has plunged by -4.87 when compared to previous closing price of 56.62, but the company has seen a -5.08% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-08 that Nutrien’s Q1 2025 results do not change the long-term thesis, but investors might need to adjust their near-term expectations. Lower net selling prices in conjunction with cost pressures are likely to continue to put pressure on margins in the coming months. Based on current expectations about the rest of 2025, the recent share price rally appears to have been premature.
Is It Worth Investing in Nutrien Ltd (NYSE: NTR) Right Now?
Nutrien Ltd (NYSE: NTR) has a higher price-to-earnings ratio of 39.52x compared to its average ratio. NTR has 36-month beta value of 0.84. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 8 as “overweight,” 7 as “hold,” and 1 as “sell.”
The public float for NTR is 488.24M, and currently, short sellers hold a 2.72% ratio of that float. The average trading volume of NTR on May 08, 2025 was 2.49M shares.
NTR’s Market Performance
NTR’s stock has seen a -5.08% decrease for the week, with a 14.89% rise in the past month and a 6.65% gain in the past quarter. The volatility ratio for the week is 1.61%, and the volatility levels for the past 30 days are at 2.80% for Nutrien Ltd The simple moving average for the last 20 days is -0.50% for NTR stock, with a simple moving average of 9.19% for the last 200 days.
Analysts’ Opinion of NTR
Many brokerage firms have already submitted their reports for NTR stocks, with Goldman repeating the rating for NTR by listing it as a “Sell.” The predicted price for NTR in the upcoming period, according to Goldman is $53 based on the research report published on March 13, 2025 of the current year 2025.
Barclays, on the other hand, stated in their research note that they expect to see NTR reach a price target of $56, previously predicting the price at $55. The rating they have provided for NTR stocks is “Equal Weight” according to the report published on January 21st, 2025.
Piper Sandler gave a rating of “Overweight” to NTR, setting the target price at $58 in the report published on January 13th of the current year.
NTR Trading at 3.71% from the 50-Day Moving Average
After a stumble in the market that brought NTR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.52% of loss for the given period.
Volatility was left at 2.80%, however, over the last 30 days, the volatility rate increased by 1.61%, as shares surge +11.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.92% upper at present.
During the last 5 trading sessions, NTR fell by -4.46%, which changed the moving average for the period of 200-days by +7.50% in comparison to the 20-day moving average, which settled at $54.15. In addition, Nutrien Ltd saw 20.36% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NTR
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.29 for the gross margin
The net margin for Nutrien Ltd stands at 0.03. The total capital return value is set at 0.03. Equity return is now at value 2.72, with 1.29 for asset returns.
Based on Nutrien Ltd (NTR), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 1.64.
Currently, EBITDA for the company is 4.94 billion with net debt to EBITDA at 2.87. When we switch over and look at the enterprise to sales, we see a ratio of 1.49. The receivables turnover for the company is 4.77for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
To put it simply, Nutrien Ltd (NTR) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
